KYLE CHENG: Open Payments
NPI 1306103064 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,118 in 73 payments from 14 companies in 2025. Trend: 2023 $3,952 · 2024 $3,504 · 2025 $3,118
Food & beverage: $1,723Consulting: $1,300Education: $95
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $1,399 |
| Galderma Laboratories, L.P. | 31 | $654 |
| Janssen Biotech, Inc. | 11 | $284 |
| ABBVIE INC. | 8 | $183 |
| Blueprint Medicines Corporation | 1 | $131 |
| Novartis Pharmaceuticals Corporation | 2 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $78 |
| Arcutis Biotherapeutics, Inc. | 3 | $73 |
| Incyte Corporation | 3 | $62 |
| LEO Pharma Inc. | 3 | $53 |
Products named: Bimzelx, NEMLUVIO, TREMFYA, RINVOQ, AYVAKIT, ILUMYA, Zoryve, OPZELURA.
Industry payments across CA — which companies pay providers there.
